Traws Pharma Inc (TRAW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,503 | -20,410 | -24,092 | -19,667 | -24,023 |
| Depreciation Amortization | 14 | 55 | 88 | 96 | 150 |
| Accounts receivable | -63 | 24 | -28 | 1,473 | -1,372 |
| Accounts payable and accrued liabilities | 232 | -1,454 | 863 | 1,902 | -606 |
| Other Working Capital | -327 | -1,067 | 102 | 3,817 | -11,173 |
| Other Operating Activity | 816 | 156 | -753 | -3,434 | 5,786 |
| Operating Cash Flow | $-20,831 | $-22,696 | $-23,820 | $-15,813 | $-31,238 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -55 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-55 | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 26,648 | 35,657 | 6,360 | 17,423 | 7,464 |
| Financing Cash Flow | $26,648 | $35,657 | $6,360 | $17,423 | $7,464 |
| Exchange Rate Effect | -6 | -15 | 34 | -9 | -9 |
| Beginning Cash Position | 16,970 | 4,024 | 21,450 | 19,849 | 43,582 |
| End Cash Position | 22,726 | 16,970 | 4,024 | 21,450 | 19,799 |
| Net Cash Flow | $5,756 | $12,946 | $-17,426 | $1,601 | $-23,783 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,831 | -22,696 | -23,820 | -15,813 | -31,238 |
| Capital Expenditure | -55 | 0 | N/A | N/A | N/A |
| Free Cash Flow | -20,886 | -22,696 | -23,820 | -15,813 | -31,238 |